Beauvericin induced erythrocyte cell membrane scrambling

Syed M Qadri1, Yuliya Kucherenko, Florian Lang

  • 1Department of Physiology, University of Tübingen, Gmelinstr. 5, 72076 Tübingen, Germany.

Toxicology
|February 8, 2011
PubMed

Insights

Beauvericin mycotoxin induces eryptosis, a form of red blood cell death, by increasing calcium and decreasing ATP. It also affects cell shrinkage during energy depletion.

Area of Science:

  • Mycotoxicology
  • Cell Biology
  • Physiology

Background:

  • Beauvericin is a mycotoxin with diverse biological activities.
  • Eryptosis, or suicidal erythrocyte death, involves cell shrinkage and phosphatidylserine exposure.
  • Eryptosis can be triggered by energy depletion and increased cytosolic calcium.

Purpose of the Study:

  • To investigate if beauvericin induces eryptosis.
  • To determine how beauvericin influences eryptosis under energy-depleted conditions.

Main Methods:

  • Assessed phosphatidylserine exposure using annexin V binding.
  • Measured cell volume via forward scatter in FACS analysis.
  • Quantified cytosolic calcium and ATP concentrations.
  • Examined ion channel activity using whole-cell patch clamp.

Main Results:

  • Beauvericin (≥ 5 μM) decreased erythrocyte ATP and increased cytosolic calcium and annexin V binding.
  • Beauvericin's effect on annexin V binding was reduced by removing extracellular calcium.
  • Beauvericin (≥ 1 μM) enhanced calcium and annexin V increases during glucose depletion.
  • Beauvericin inhibited calcium-activated potassium channels, blunting cell shrinkage during glucose depletion.

Conclusions:

  • Beauvericin stimulates calcium entry, leading to erythrocyte membrane scrambling.
  • Beauvericin inhibits calcium-activated potassium channels, impacting cell shrinkage during energy depletion.
  • These findings reveal novel mechanisms of beauvericin's action on erythrocytes.